Stem Cell Preservation: Why It Matters and How It Works

A baby’s umbilical cord blood and cord tissue contain valuable stem cells that can only be collected at the time of birth. These stem cells are already being used in the treatment of several blood-related and immune disorders, while ongoing research continues to explore their role in regenerative medicine and future therapies.

Stem cell preservation gives families the opportunity to store these cells for potential medical use later in life. As awareness around preventive healthcare and future treatment options grows, many expectant parents are choosing to understand how stem cell preservation works, why timing matters, and what factors should be considered before making a decision. To help, in this blog, we will discuss the science behind stem cell preservation, its potential benefits, the collection and storage process, and the key factors to consider when choosing a stem cell bank.

What Exactly Is Stem Cell Preservation?

Stem cell preservation is the process of collecting, processing, and storing stem cells from the umbilical cord blood and cord tissue immediately after childbirth for potential future medical use. These stem cells are preserved in specialised cryogenic storage facilities under carefully controlled conditions designed to maintain long-term cell viability.

The stem cells collected at birth are biologically important because they can self-renew and develop into specialised cells involved in blood formation, immune function, and connective tissue repair. Unlike stem cells collected later in life through bone marrow or peripheral blood procedures, cord-derived stem cells are obtained through a non-invasive collection process performed only once, i.e. after the umbilical cord is clamped and cut.

Because the cord blood and cord tissue are typically discarded after delivery, childbirth provides a unique opportunity to preserve these clinically relevant cells at an early stage of life.

Read Also: Stem Cell Preservation Cost in India: Everything You Need to Know

Types of Stem Cells Collected at Birth

Families may choose either private preservation or public donation. In private preservation, the stored sample remains reserved for the child or eligible family members for the duration of the storage plan. In public donation, the sample is added to a public registry and may potentially be used for compatible patients requiring stem cell transplantation. While public donation contributes to broader healthcare needs, the donated sample may not remain available for future personal use by the donor family.

Why Are Stem Cells Clinically Significant?

Stem cells play an important role in modern medicine because of their ability to support the formation and repair of different types of cells within the body. Their clinical significance is based on two key biological properties:

• Self-renewal: The ability to replicate and maintain a stem cell population over time
• Differentiation: The ability to develop into specialised cell types involved in blood formation, immune responses, and connective tissue support

Cord blood stem cells are already used in established haematopoietic stem cell transplantation for select blood disorders, immune deficiencies, and inherited metabolic conditions. Cord tissue-derived stem cells, particularly mesenchymal stem cells, continue to be studied for their potential role in regenerative medicine and tissue repair research.

Compared to some adult-derived stem cell sources, cord-derived stem cells are collected very early in life before prolonged exposure to environmental stressors, infections, and age-related cellular changes. They are also considered immunologically less mature, which may provide greater flexibility in donor-recipient matching in certain transplant settings.

Current Uses and Ongoing Research

Some applications of cord blood stem cells are already well established in transplant medicine, while several other areas remain under active clinical investigation.

Established Clinical Applications of Cord Blood Stem Cells

Cord blood stem cells are currently used in haematopoietic stem cell transplantation for certain conditions such as:

• Leukaemia and lymphoma
• Thalassaemia and sickle cell anaemia
• Aplastic anaemia and selected bone marrow disorders
• Certain immune deficiency disorders such as SCID
• Selected inherited metabolic conditions

Ongoing Areas of Research

Researchers are also studying the potential role of cord blood and cord tissue stem cells in regenerative and cellular medicine, including:

• Neurological research involving cerebral palsy and stroke
• Autoimmune and inflammatory disorders such as type 1 diabetes and lupus
• Tissue repair research involving cardiac tissue, spinal cord injury, and musculoskeletal conditions
• Metabolic and vascular research

Many regenerative medicine applications remain investigational, and additional clinical studies are required to evaluate their long-term safety, effectiveness, and clinical suitability.

Read Also: What is Stem Cell Preservation? Uses, Benefits, and Process in India

Benefits and Limitations of Stem Cell Preservation

Stem cell preservation is often viewed as a form of long-term biological preparedness, allowing families to store clinically relevant stem cells collected at birth for potential future medical use. However, understanding both the potential benefits and the current limitations is important before making a decision.

Potential Benefits

Access to preserved stem cells when needed: When properly processed and cryopreserved, preserved stem cells may be available for future access without the delays sometimes associated with donor searches and collection procedures.

Potential family compatibility: Biological siblings may sometimes share compatible stem cell markers, which may increase the potential utility of preserved stem cells for family use in certain medical situations.

Established transplant applications: Cord blood stem cells are already used in established haematopoietic stem cell transplantation for select blood, immune, and metabolic disorders.

Ongoing advances in regenerative medicine: Research involving cord blood and cord tissue stem cells continues to expand in areas such as tissue repair, immune modulation, and regenerative medicine.

Safe and non-invasive collection: Collection takes place only after the umbilical cord is clamped and cut and is generally considered safe for both the mother and baby.

Important Limitations to Understand

While stem cell preservation offers potential future value, it is important to recognise that preservation does not guarantee future treatment or clinical outcomes.

• The suitability of stem cell use depends on the medical condition, donor compatibility, and clinical eligibility
• Many regenerative medicine applications are still under investigation and are not yet considered standard treatment
• In some situations, a patient’s own preserved stem cells may not be clinically appropriate for treatment
• Long-term value depends significantly on laboratory processing quality, cryopreservation standards, and storage infrastructure

For many families, stem cell preservation is therefore considered a proactive healthcare decision that keeps future therapeutic possibilities available under appropriate medical guidance and evolving clinical practice.

Read Also: If the Science Is Promising, Why Isn’t Cord Blood and Tissue Storage More Common?

Choosing the Right Stem Cell Bank

The quality of stem cell preservation depends not only on collection, but also on how the sample is processed, tested, cryopreserved, and monitored over time. Since stem cells are intended for long-term storage, families should carefully evaluate the following factors when selecting a stem cell bank:

• Regulatory accreditation and compliance: Look for stem cell banks that follow recognised quality standards and hold relevant national or international accreditations, such as the Association for the Advancement of Blood & Biotherapies (AABB) and the College of American Pathologists (CAP), along with licensing and regulatory approvals applicable in India, including oversight by the Drug Controller General of India (DCGI) where relevant.
• Laboratory processing standards: Processing quality plays an important role in stem cell recovery and preservation. Families should consider whether the laboratory uses validated processing systems, automated technologies, and controlled handling procedures to support consistency.
• Quality testing before Storage: Before cryopreservation, samples should undergo laboratory evaluation for parameters such as cell count, cell viability, sterility, and sample integrity before approval for long-term cryogenic storage.
• Cryogenic storage infrastructure: Look for dedicated cryogenic storage facilities, continuous environmental and temperature monitoring systems, backup infrastructure, and contingency protocols designed to maintain uninterrupted storage conditions.
• Operational experience and sample release history: A documented track record of therapeutic sample releases may provide insight into the laboratory’s clinical coordination experience and long-term operational capability.

Why Cryoviva Life Sciences Stands Apart

At Cryoviva Life Sciences, stem cell preservation is supported by established laboratory practices, quality systems, and long-term cryogenic storage infrastructure designed to maintain sample integrity and preservation standards throughout the storage period.

Key operational and infrastructure highlights include:

• Licensed by the Drug Controller General of India (DCGI)
• Quality systems aligned with internationally recognised standards and accreditations, including ISO and CAP frameworks
• Exclusive India partner for PrepaCyte®-CB automated processing technology, available with selected preservation plans including Blessing, Supra Superior, and Supra Ultimate
• Four dedicated cryogenic storage centres supported by continuous environmental monitoring systems
• Network of 350 trained scientific and medical professionals involved in preservation, processing, and storage operations
• More than 3.5 lakh families served across 250 cities in India

Cryoviva Life Sciences has also reported therapeutic sample releases involving conditions such as leukaemia, thalassaemia, cerebral palsy, and autism spectrum disorder. The clinical suitability of preserved stem cells depends on medical indication, patient eligibility, donor compatibility, and specialist evaluation.

The organisation was recognised as the Most Promising Company in Genomic Science and Regenerative Medicine at the 16th MT India Healthcare Awards 2026.

The Cryoviva Life Sciences Approach to Stem Cell Preservation

Cryoviva Life Sciences follows a multi-stage preservation process designed to support controlled handling, laboratory quality, and long-term cryogenic storage at every stage. The preservation process includes: 

Collection

Stem cells are collected from the umbilical cord immediately after birth through a process that is generally considered non-invasive and safe for both the mother and baby.

In many situations, cord blood collection and delayed cord clamping may be compatible when planned in advance with the healthcare team. As timing and duration of delayed cord clamping can influence the volume of cord blood available for preservation, families are encouraged to discuss their preferences with their obstetrician or delivery team during birth planning so that clinical priorities and collection procedures can be appropriately coordinated.

Processing

Following collection, samples are transported to a GMP-certified laboratory for processing under controlled conditions. Cryoviva Life Sciences is the exclusive India partner for PrepaCyte®-CB automated processing technology, designed to support stem cell recovery, reduce unwanted red blood cell content, and improve processing consistency.

Processing outcomes may vary depending on factors such as collection quality, sample volume, transport conditions, and laboratory protocols.

Quality Assessment

Before cryopreservation, each sample undergoes laboratory evaluation for:

• Cell count
• Cell viability
• Sterility
• Sample integrity and processing quality

Only samples meeting defined laboratory quality parameters proceed to long-term cryogenic storage.

Cryopreservation and Long-Term Storage

Processed stem cells are cryopreserved using controlled-rate freezing protocols and stored under continuously monitored cryogenic conditions designed to support long-term preservation stability.

Cryoviva Life Sciences offers storage plans ranging from 21 years to lifetime preservation options of up to 75 years, with extended storage add-on options available.

Read Also: 8 Reasons to Choose Cryoviva Life Sciences for Stem Cell Preservation

Is Stem Cell Preservation Worth Considering?

Choosing stem cell preservation is a personal decision that may involve medical awareness, family history, financial planning, and long-term healthcare priorities.

For some families, the decision may be influenced by a history of blood disorders, immune-related conditions, or inherited diseases where stem cell transplantation already has established applications. For others, the consideration may stem from the fact that stem cells collected at birth cannot be retrieved later, making preservation a one-time opportunity available only during childbirth.

At the same time, it is important to approach stem cell preservation with realistic expectations. Preserving stem cells does not guarantee future treatment or clinical outcomes. The suitability of preserved stem cells depends on several factors, including the medical condition, donor compatibility, patient eligibility, and evolving clinical guidelines.

As research in regenerative medicine and cellular therapy continues to advance, many families view stem cell preservation as a proactive step that keeps future therapeutic possibilities available under appropriate medical guidance.

The Right Time to Decide Is Before Delivery Day

As umbilical cord blood and cord tissue can only be collected at birth, families considering stem cell preservation are encouraged to explore available preservation options before the expected delivery date. Early planning also allows time to discuss collection preferences, delayed cord clamping considerations, storage plans, and laboratory processes with the healthcare and preservation teams.

Cryoviva Life Sciences offers multiple preservation plans designed to support different family requirements, including options ranging from standard to lifetime cryogenic storage. Preservation plans include additional support features such as treatment assistance programmes and worldwide shipment support at the time of sample retrieval, subject to applicable terms and conditions.

To learn more about cord blood and cord tissue preservation options, families may consult a specialist at Cryoviva Life Sciences before the delivery day. Simply call at 1800 101 9587 (toll-free) or schedule a consultation online.